Skip to content
10-Q

Quarterly Report

Solid Biosciences Inc. SLDB

0001193125-25-262818

← back to feed
Filed
Nov 3, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 29, 2025 77.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 94.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.07M sh
Shares Diluted Q3 2025 · Sep 30, 2024 41.44M sh
Shares Diluted Q3 2025 · Sep 30, 2024 40.18M sh
Capex Q3 2025 · Sep 30, 2025 $588K
Capex Q3 2025 · Sep 30, 2024 $450K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$102.73M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$70.37M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $61.36M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $80.24M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $64.39M
Stockholders Equity Q3 2025 · Sep 30, 2025 $217.95M
Stockholders Equity Q3 2025 · Jun 30, 2025 $258.29M
Stockholders Equity Q3 2025 · Mar 31, 2025 $294.46M
Stockholders Equity Q3 2025 · Dec 31, 2024 $137.25M
Stockholders Equity Q3 2025 · Sep 30, 2024 $167.02M
Stockholders Equity Q3 2025 · Jun 30, 2024 $193.25M
Stockholders Equity Q3 2025 · Mar 31, 2024 $210.72M
Stockholders Equity Q3 2025 · Dec 31, 2023 $126.48M
Current Liabilities Q3 2025 · Sep 30, 2025 $36.34M
Current Liabilities Q3 2025 · Dec 31, 2024 $30.26M
Total Liabilities Q3 2025 · Sep 30, 2025 $55.97M
Total Liabilities Q3 2025 · Dec 31, 2024 $51.42M
Current Assets Q3 2025 · Sep 30, 2025 $244.85M
Current Assets Q3 2025 · Dec 31, 2024 $157.3M
Total Assets Q3 2025 · Sep 30, 2025 $273.91M
Total Assets Q3 2025 · Dec 31, 2024 $188.66M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.46
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.79
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.48
Eps Basic Q3 2025 · Sep 30, 2025 −$1.46
Eps Basic Q3 2025 · Sep 30, 2024 −$0.79
Eps Basic Q3 2025 · Sep 30, 2024 −$2.04
Sga Expense Q3 2025 · Sep 30, 2025 $9.2M
Sga Expense Q3 2025 · Sep 30, 2025 $27.61M
Sga Expense Q3 2025 · Sep 30, 2024 $7.86M
Sga Expense Q3 2025 · Sep 30, 2024 $24.17M
Rd Expense Q3 2025 · Sep 30, 2025 $38.86M
Rd Expense Q3 2025 · Sep 30, 2025 $102.19M
Rd Expense Q3 2025 · Sep 30, 2024 $27.33M
Rd Expense Q3 2025 · Sep 30, 2024 $65.66M
Operating Income Q3 2025 · Sep 30, 2025 −$48.06M
Operating Income Q3 2025 · Sep 30, 2025 −$129.8M
Operating Income Q3 2025 · Sep 30, 2024 −$35.18M
Operating Income Q3 2025 · Sep 30, 2024 −$89.83M